National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting, 27273-27274 [2017-12241]
Download as PDF
Federal Register / Vol. 82, No. 113 / Wednesday, June 14, 2017 / Notices
Dated: June 9, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–12299 Filed 6–13–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
mstockstill on DSK30JT082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Career Development Program to Promote
Diversity in Health Research.
Date: July 6, 2017.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Lindsay Marie Garvin,
Ph.D., Scientific Review Officer, National
Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Suite 7189, Bethesda, MD
20892, 301–827–7911, lindsay.garvin@
nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Biorepository: Scientific
Opportunities for Exploratory Research
(R21).
Date: July 7, 2017.
17:36 Jun 13, 2017
Jkt 241001
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal City Marriott, 1999 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: William J. Johnson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7178, Bethesda, MD 20892–7924, 301–827–
7938, johnsonwj@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Short-Term Research Education to Increase
Diversity.
Date: July 7, 2017.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Lindsay Marie Garvin,
Ph.D., Scientific Review Officer, National
Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Suite 7189, Bethesda, MD
20892, 301–827–7911, lindsay.garvin@
nih.gov.
Date: June 29–30, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 814,
Bethesda, MD 20892, 301–451–4838, mak2@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
also be Webcast. Additional information
about accessing the Webcast will be
made available at least 2 days prior to
the public workshop at: https://
www.fda.gov/Drugs/NewsEvents/
ucm540845.htm.
Transcripts: Please be advised that as
soon as a transcript of the public
workshop is available, it will be
accessible at https://
www.regulations.gov. It may be viewed
at the Division of Dockets Management
(see ADDRESSES). A link to the transcript
will also be available on the Internet at
https://www.fda.gov/Drugs/NewsEvents/
ucm540845.htm.
VerDate Sep<11>2014
27273
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 8, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12239 Filed 6–13–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; P30 Core
Centers for Clinical Research.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: June 8, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12240 Filed 6–13–17; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Training
Grants Review.
Date: June 20, 2017.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Suite 824, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Yin Liu, Ph.D., MD,
Scientific Review Officer, Scientific Review
Branch, National Institute of Health/NIAMS,
6701 Democracy Blvd., Suite 824, Bethesda,
MD 20892, 301–594–4952, liuy@
exchange.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
E:\FR\FM\14JNN1.SGM
14JNN1
27274
Federal Register / Vol. 82, No. 113 / Wednesday, June 14, 2017 / Notices
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: June 8, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12241 Filed 6–13–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
New Date for the October 2017
Customs Broker’s License
Examination
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
AGENCY:
This document announces
that U.S. Customs and Border Protection
has changed the date on which the
semi-annual examination for an
individual broker’s license will be held
in October 2017.
DATES: The customs broker’s license
examination scheduled for October 2017
will be held on Wednesday, October 25,
2017.
FOR FURTHER INFORMATION CONTACT:
Neila Venne, Broker Management
Branch, Office of Trade, (843) 579–6407,
Neila.M.Venne@cbp.dhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
mstockstill on DSK30JT082PROD with NOTICES
Background
Dated: June 7, 2017.
Brenda B. Smith,
Executive Assistant Commissioner, Office of
Trade, U.S. Customs and Border Protection.
[FR Doc. 2017–12311 Filed 6–13–17; 8:45 am]
BILLING CODE 9111–14–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
[Docket No. DHS–2017–0019]
Section 641 of the Tariff Act of 1930,
as amended (19 U.S.C. 1641), provides
that a person (an individual,
corporation, association, or partnership)
must hold a valid customs broker’s
license and permit in order to transact
customs business on behalf of others,
sets forth standards for the issuance of
broker’s licenses and permits, and
provides for the taking of disciplinary
action against brokers that have engaged
in specified types of infractions. This
section also provides that an
examination may be conducted to assess
an applicant’s qualifications for a
license.
The regulations issued under the
authority of section 641 are set forth in
Title 19 of the Code of Federal
Regulations, part 111 (19 CFR 111). Part
111 sets forth the regulations regarding
the licensing of, and granting of permits
to, persons desiring to transact customs
business as customs brokers. These
regulations also include the
qualifications required of applicants and
the procedures for applying for licenses
VerDate Sep<11>2014
and permits. Section 111.11 of the CBP
Regulations (19 CFR 111.11) sets forth
the basic requirements for a broker’s
license and in paragraph (a)(4) of that
section provides that an applicant for an
individual broker’s license must attain a
passing grade (75 percent or higher) on
a written examination.
Section 111.13 of the CBP Regulations
(19 CFR 111.13) sets forth the
requirements and procedures for the
written examination for an individual
broker’s license and states that written
customs broker license examinations
will be given on the first Monday in
April and October unless the regularly
scheduled examination date conflicts
with a national holiday, religious
observance, or other foreseeable event.
To avoid concerns related to the
commencement of the federal
government’s 2018 fiscal year, CBP has
decided to change the regularly
scheduled date of the examination. This
document announces that CBP has
scheduled the October 2017 customs
broker’s license examination for
Wednesday, October 25, 2017.
17:36 Jun 13, 2017
Jkt 241001
Privacy Act of 1974; System of
Records
Privacy Office, Department of
Homeland Security.
ACTION: Notice of modified Privacy Act
System of Records.
AGENCY:
In accordance with the
Privacy Act of 1974, the Department of
Homeland Security proposes to modify
and reissue a current Department of
Homeland Security system of records
titled, ‘‘Department of Homeland
Security/ALL–025 Law Enforcement
Authority in Support of the Protection
of Property Owned, Occupied, or
Secured by the Department of
Homeland Security System of Records.’’
This system of records allows the
Department of Homeland Security to
collect and maintain records on the
results of law enforcement activities in
support of the protection of property
owned, occupied, or secured by the
Department of Homeland Security and
its Components, including the Federal
SUMMARY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Protective Service, and individuals
maintaining a presence or access to such
property. The Department of Homeland
Security is updating this system of
records notice to, among other things,
(1) modify the category of individuals,
(2) modify the category of records, (3)
modify two existing routine uses, and
(4) add a new routine use. The
Department of Homeland Security is
also issuing a Notice of Proposed
Rulemaking to add a new exemption
from certain provisions of the Privacy
Act, elsewhere in the Federal Register.
This new exemption is needed to
protect information relating to DHS
activities from disclosure to subjects or
others related to these activities.
Specifically, the additional exemptions
are required to preclude subjects of
these activities from frustrating ongoing
operations; to avoid disclosure of
activity techniques; to protect the
identities and physical safety of
confidential informants and law
enforcement personnel; to ensure DHS’s
ability to obtain information from third
parties and other sources; to protect the
privacy of third parties; and to safeguard
classified information. Disclosure of
information to the subject of the inquiry
could also permit the subject to avoid
detection or apprehension. The existing
Privacy Act exemptions for this system
of records continue to apply to it.
Additionally, this notice includes nonsubstantive changes to simplify the
formatting and text of the previously
published notice.
This system of records notice does not
apply to the facilities and perimeters
secured by the U.S. Secret Service.
Records pertaining to perimeters and
facilities secured by the U.S. Secret
Service, other than those records subject
to the Presidential Records Act, are
covered under Department of Homeland
Security/U.S. Secret Service-004
Protection Information System of
Records, 76 FR 66940, October 28, 2011.
This modified system will be
included in the Department of
Homeland Security’s inventory of
record systems.
DATES: Submit comments on or before
July 14, 2017. This modified system will
be effective July 14, 2017.
ADDRESSES: You may submit comments,
identified by docket number DHS–
2017–0019 by one of the following
methods:
• Federal e-Rulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Fax: 202–343–4010.
• Mail: Jonathan R. Cantor, Acting
Chief Privacy Officer, Privacy Office,
E:\FR\FM\14JNN1.SGM
14JNN1
Agencies
[Federal Register Volume 82, Number 113 (Wednesday, June 14, 2017)]
[Notices]
[Pages 27273-27274]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12241]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; Training
Grants Review.
Date: June 20, 2017.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Blvd., Suite 824, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Yin Liu, Ph.D., MD, Scientific Review Officer,
Scientific Review Branch, National Institute of Health/NIAMS, 6701
Democracy Blvd., Suite 824, Bethesda, MD 20892, 301-594-4952,
liuy@exchange.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis,
[[Page 27274]]
Musculoskeletal and Skin Diseases Research, National Institutes of
Health, HHS)
Dated: June 8, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-12241 Filed 6-13-17; 8:45 am]
BILLING CODE 4140-01-P